ReShape Lifesciences Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
ReShape Lifesciences Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • ReShape Lifesciences Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $27K, a 69% decline year-over-year.
  • ReShape Lifesciences Inc. annual Operating Lease, Payments for 2023 was $228K, a 59.3% decline from 2022.
  • ReShape Lifesciences Inc. annual Operating Lease, Payments for 2022 was $560K, a 0.89% decline from 2021.
  • ReShape Lifesciences Inc. annual Operating Lease, Payments for 2021 was $565K, a 183% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $27K -$60K -69% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $87K -$113K -56.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $200K +$100K +100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $100K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-12
Q2 2020 $500K $100K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $500K $100K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2020-06-19
Q4 2019 $500K $200K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $100K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $100K Apr 1, 2019 Jun 30, 2019 10-Q 2019-07-24
Q1 2019 $100K Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.